Examine the role of WHO and the International Health Regulations in containing cross-border disease outbreaks. How prepared is India for imported high-consequence infectious diseases?

The International Health Regulations (IHR) 2005 are binding international law, in force since 2007. They make WHO the global hub for detecting, reporting and coordinating action on cross-border health risks [3]. In October 2026 Nigeria confirmed an imported Ebola case, the first in West Africa in this outbreak [1]. That case tests both this system and India's readiness.

Role of WHO and IHR: Strengths

• Early warning: states must notify WHO within 24 hours of assessing a possible emergency, through their National IHR Focal Points [3].
• Emergency declaration: WHO declared the Bundibugyo epidemic in DRC and Uganda a Public Health Emergency of International Concern (PHEIC) on 17 May 2026. An Emergency Committee then issued temporary recommendations to states [2].
• Access to vaccines and tests: 70,000 Ervebo doses were released from the global stockpile. Of these, 50,000 went to health workers and 20,000 to a Phase 3 trial [5]. WHO also put the first Bundibugyo test on its Emergency Use Listing [6].
• Points of entry: the IHR require basic surveillance capacity at airports, ports and land crossings [3].

Limitations

• No proven vaccine: there is no licensed Bundibugyo vaccine. The DRC had 5,794 cases and 2,786 deaths by August 2026, even after the PHEIC [4].
• No enforcement: compliance depends on each country's capacity. The case reaching Nigeria shows that border controls let cases through [1].
• Screening blind spot: a 2–21 day incubation period means infected travellers pass fever scanners before they fall sick [7].

India's Preparedness

• Surveillance: IDSP's Integrated Health Information Platform (IHIP) gives case-based, near-real-time reporting from all States/UTs [8].
• Lab capacity: ICMR-NIV Pune runs a BSL-4 lab and has experience containing Nipah [9].
• Gaps:
• Airport fever checks miss travellers who are still incubating. Following up arrivals for 21 days matters more [7].
• Top-level labs are concentrated in a few centres.
• Surveillance at district level is uneven.
• India depends on global supplies of vaccines for rare viruses.

Detect (IHIP) → Notify WHO in 24h (IHR) → Isolate + 21-day follow-up → Confirm (NIV BSL-4)

Flow of India's response to an imported case

The WHO–IHR system provides the structure for joint action, but national capacity decides whether a response works. India should:

• run 21-day traveller follow-up through IHIP;
• add more BSL-3/4 labs across regions;
• co-fund vaccine research for neglected pathogens under a One Health approach.

This would advance SDG 3.d on early warning and management of global health risks.